Profile
Mr. Chang, received his M.D.
and M.B.A.
degrees in healthcare management from Tufts Medical School, and his B.A.
in biochemistry from the University of Pennsylvania.
He has also worked in business development and planning in the biotechnology and medical devices sectors, where he assessed research and development collaboration deals, identified market opportunities, and planned product launches.
Former positions of Wellington Chang
| Companies | Position | End |
|---|---|---|
WR Hambrecht + Co. LLC
 WR Hambrecht + Co. LLC Investment Banks/BrokersFinance Founded in 1998 by William R. Hambrecht, WR Hambrecht + Co. LLC is a registered broker/dealer headquartered in San Francisco, California. The firm offers a full array of investment services. They provide research that focuses on the (1) Asia-Pacific, biotechnology, business applications and services sectors (2) the China Internet and technology sector (3) consumer (4) enterprise software and Internet (5) gaming technology (6) Internet (7) medical technology (8) nanotechnology (9) networking and data infrastructure (10) semiconductors and devices and (11) specialty pharmaceuticals. | Analyst-Equity | 30/10/2006 |
| Advest, Inc. | Analyst-Equity | 13/10/2005 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
| Advest, Inc. | Finance |
WR Hambrecht + Co. LLC
WR Hambrecht + Co. LLC Investment Banks/BrokersFinance Founded in 1998 by William R. Hambrecht, WR Hambrecht + Co. LLC is a registered broker/dealer headquartered in San Francisco, California. The firm offers a full array of investment services. They provide research that focuses on the (1) Asia-Pacific, biotechnology, business applications and services sectors (2) the China Internet and technology sector (3) consumer (4) enterprise software and Internet (5) gaming technology (6) Internet (7) medical technology (8) nanotechnology (9) networking and data infrastructure (10) semiconductors and devices and (11) specialty pharmaceuticals. | Finance |
- Stock Market
- Insiders
- Wellington Chang
